Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eszter Dalma, Pálinkás"'
Autor:
Róbert Sepp, Lidia Hategan, Beáta Csányi, János Borbás, Annamária Tringer, Eszter Dalma Pálinkás, Viktória Nagy, Hedvig Takács, Dóra Latinovics, Noémi Nyolczas, Attila Pálinkás, Réka Faludi, Miklós Rábai, Gábor Tamás Szabó, Dániel Czuriga, László Balogh, Róbert Halmosi, Attila Borbély, Tamás Habon, Zoltán Hegedűs, István Nagy
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1132 (2022)
Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium most commonly caused by mutations in sarcomeric genes. We aimed to perform a nationwide large-scale genetic analysis of a previously unreported, representative HCM cohort in Hun
Externí odkaz:
https://doaj.org/article/6362fa260e40429f98fc1d13dc6de1c2
Autor:
Eszter Dalma, Pálinkás, Federica, Re, Jesus, Peteiro, Milorad, Tesic, Attila, Pálinkás, Marco Antonio Rodrigues, Torres, Ana Djordjevic, Dikic, Branko, Beleslin, Caroline M, Van De Heyning, Maria Grazia, D'Alfonso, Fabio, Mori, Quirino, Ciampi, José Luis, de Castro Silva Pretto, Iana, Simova, Viktória, Nagy, Krisztina, Boda, Róbert, Sepp, Iacopo, Olivotto, Patricia A, Pellikka, Eugenio, Picano
Publikováno v:
The international journal of cardiovascular imaging
Background B-lines detected by lung ultrasound (LUS) during exercise stress echocardiography (ESE), indicating pulmonary congestion, have not been systematically evaluated in patients with hypertrophic cardiomyopathy (HCM). Aim To assess the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ae50d4ce45bdae0d7f99a013c5919874
https://doi.org/10.1007/s10554-022-02620-0
https://doi.org/10.1007/s10554-022-02620-0
Autor:
Francesca Girolami, Alessia Gozzini, Eszter Dalma Pálinkás, Adelaide Ballerini, Alessia Tomberli, Katia Baldini, Alberto Marchi, Mattia Zampieri, Silvia Passantino, Giulio Porcedda, Giovanni Battista Calabri, Elena Bennati, Gaia Spaziani, Lia Crotti, Franco Cecchi, Silvia Favilli, Iacopo Olivotto
Publikováno v:
Journal of Clinical Medicine. 12:2489
Genetic counselling and genetic testing in hypertrophic cardiomyopathy (HCM) represent an integral part of the diagnostic algorithm to confirm the diagnosis, distinguish it from phenocopies, and suggest tailored therapeutic intervention strategies. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615352fa67a7a8e643f2e14f5b7f74d5
https://doi.org/10.3390/jcm12072489
https://doi.org/10.3390/jcm12072489